Effect of Osimertinib in Combination With Chemotherapy and Bevacizumab for Untreated Epidermal Growth Factor Receptor –Mutated Advanced Non-Small-Cell Lung Cancer: Case Report

Conclusions: The patient benefited from treatment with osimertinib in combination with chemotherapy and bevacizumab.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research